A study by Rodrigues dos Santos et al. demonstrated that breast cancer patients with elevated LDL-C at diagnosis had significantly larger tumors, higher histological grades, increased Ki-67 proliferation indices, and a more frequent HER2-positive status, suggesting that systemic cholesterol plays a role in cancer’s progression. The gene discussed is ERBB2; the disease is breast carcinoma.